A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinumâresistant metastatic urothelial cancer
Zhang, Tian, Harrison, Michael R., O'Donnell, Peter H., Alva, Ajjai S., Hahn, Noah M., Appleman, Leonard J., Cetnar, Jeremy, Burke, John M., Fleming, Mark T., Milowsky, Matthew I., Mortazavi, Amir, ShJournal:
Cancer
DOI:
10.1002/cncr.33067
Date:
August, 2020
File:
PDF, 536 KB
2020